Kristalose Related Published Studies
Well-designed clinical trials related to Kristalose (Lactulose)
Secondary prophylaxis of hepatic encephalopathy: an open-label randomized controlled trial of lactulose versus placebo. [2009.09]
A dietary fiber mixture versus lactulose in the treatment of childhood constipation: a double-blind randomized controlled trial. [2008.11]
An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy. [2008.06]
Effects of therapeutic doses of lactulose vs. polyethylene glycol on isotopic colonic transit. [2008.05]
Laxation of critically ill patients with lactulose or polyethylene glycol: a two-center randomized, double-blind, placebo-controlled trial. [2007.12]
Laxation of critically ill patients with lactulose or polyethylene glycol: A two-center randomized, double-blind, placebo-controlled trial* [2007.09.19]
Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study. [2007.09.04]
Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. [2007.03]
Efficacy of oral L-ornithine-L-aspartate in cirrhotic patients with hyperammonemic hepatic encephalopathy. Results of a randomized, lactulose-controlled study. [2006.10]
L-rhamnose and lactulose decrease serum triacylglycerols and their rates of synthesis, but do not affect serum cholesterol concentrations in men. [2006.08]
Prospective randomized crossover trial comparing fibre with lactulose in the treatment of idiopathic chronic constipation. [2006.07]
Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial. [2006.04.15]
Effect of lactulose and Saccharomyces boulardii administration on the colonic urea-nitrogen metabolism and the bifidobacteria concentration in healthy human subjects. [2006.04.01]
Colonic fermentation from lactulose inhibits lipolysis in overweight subjects. [2005.10]
Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study. [2005.06.30]
Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B. [2005.05.21]
Ineffectiveness of Lactobacillus GG as an adjunct to lactulose for the treatment of constipation in children: a double-blind, placebo-controlled randomized trial. [2005.03]
A comparative study: the efficacy of liquid paraffin and lactulose in management of chronic functional constipation. [2005.02]
Evaluation of rifaximin, placebo and lactulose in reducing the levels of benzodiazepine-like compounds in patients with liver cirrhosis: a pilot study. [2005]
L-Rhamnose increases serum propionate after long-term supplementation, but lactulose does not raise serum acetate. [2004.11]
PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial. [2004.11]
Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. [2004.04.15]
Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. [2004.03]
[Effects of lactulose treatment on the course of subclinical hepatic encephalopathy] [2003.07.10]
[Long-term efficacy of lactulose in patients with subclinical hepatic encephalopathy] [2003.04]
Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. [2003.02]
Effects of melatonin and lactulose on the liver and kidneys in rats with obstructive jaundice. [2002.12]
Short duration exercise increases breath hydrogen excretion after lactulose ingestion: description of a new phenomenon. [2002.11]
Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children. [2002.05]
Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK. [2002]
Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy. [2000.08]
Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial. [2000.03]
Effects of pre- and post-absorptive factors on the lactulose/rhamnose gut permeability test. [2000.03]
Stool water content and colonic drug absorption: contrasting effects of lactulose and codeine. [1999.08]
Lactulose stimulates calcium absorption in postmenopausal women. [1999.07]
Fructooligosaccharides and lactulose cause more symptoms in lactose maldigesters and subjects with pseudohypolactasia than in control lactose digesters. [1999.05]
Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. [1999.02]
Mebeverine decreases mass movements and stool frequency in lactulose-induced diarrhoea. [1998.06]
Moderation of lactulose-induced diarrhea by psyllium: effects on motility and fermentation. [1998.02]
Efficacy of senna versus lactulose in terminal cancer patients treated with opioids. [1998.01]
A multi-centre, general practice comparison of ispaghula husk with lactulose and other laxatives in the treatment of simple constipation. [1998]
Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. [1997.12]
Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial. [1997.10]
Lactulose improves psychometric testing in cirrhotic patients with subclinical encephalopathy. [1997.02]
Chemoprevention of colorectal tumors: role of lactulose and of other agents. [1997]
Effect of lactulose on carbohydrate metabolism and diabetes mellitus. [1997]
Effects of lactulose and lactitol on colonic microflora and enzymatic activity. [1997]
[Laxative effect and tolerance of lactulose administrated in one or two intakes in the treatment of chronic idiopathic constipation. Groupe d'Investigateurs O'Ile-de-France (GIIF)] [1996]
Long-term effects of Enterococcus faecium SF68 versus lactulose in the treatment of patients with cirrhosis and grade 1-2 hepatic encephalopathy. [1995.07]
Colonic transit times and the effect of lactulose or lactitol in hospitalized patients. [1995.05]
Comparison of lactulose and inulin as reference standard for the study of resistant starch fermentation using hydrogen breath test. [1995.04]
Effect of lactose, lactulose and bisacodyl on gastrointestinal transit studied by metal detector. [1995.02]
Treatment of porto-systemic encephalopathy with lactitol verus lactulose: a randomized controlled study. [1995.01]
Wheat fibre, lactulose and rectal mucosal proliferation in individuals with a family history of colorectal cancer. [1994.12]
Lowering effects of a preparation containing fibres and lactulose on glucose and insulin levels in obesity. [1994.05]
[Lactulose-neomycin combination versus placebo in the treatment of acute hepatic encephalopathy. Results of a randomized controlled trial] [1994]
[Dimethicone in lactulose-induced dyspepsia. Effect on H2 production and symptoms] [1993.10.18]
Safety and efficacy of a bulk laxative containing senna versus lactulose in the treatment of chronic constipation in geriatric patients. [1993.10]
A comparison of Agiolax and lactulose in elderly patients with chronic constipation. [1993.10]
Chronic constipation in long stay elderly patients: a comparison of lactulose and a senna-fibre combination. [1993.09.25]
Antioxidant vitamins or lactulose for the prevention of the recurrence of colorectal adenomas. Colorectal Cancer Study Group of the University of Modena and the Health Care District 16. [1993.03]
Double-blind, double-dummy comparison between treatment with rifaximin and lactulose in patients with medium to severe degree hepatic encephalopathy. [1993]
Crystalline lactulose in the therapy of hepatic cirrhosis. Evaluation of clinical and immunological parameters. Preliminary results. [1992.07]
[A clinical comparative study of crystalline pure lactulose and powder pure lactitol in portasystemic encephalopathy of cirrhotic patients] [1991.10]
Prevention of postoperative renal dysfunction in patients with obstructive jaundice: a multicentre study of bile salts and lactulose. [1991.04]
An open, randomised, parallel group study of lactulose versus ispaghula in the treatment of chronic constipation in adults. [1991.03]
Effect of simethicone on lactulose-induced H2 production and gastrointestinal symptoms. [1991]
Comparison between lactulose-mannitol test and 51Cr-labelled ethylene diamine tetra-acetate test in inflammatory bowel diseases. [1990.12]
Cost-effective treatment of constipation in the elderly: a randomized double-blind comparison of sorbitol and lactulose. [1990.11]
Lactitol in the treatment of chronic hepatic encephalopathy--a randomized cross-over comparison with lactulose. [1990.10]
Effect of lactitol and lactulose administration on the fecal flora in cirrhotic patients. [1990.08]
Lactulose in the treatment of symptomatic diverticular disease: a comparative study with high-fibre diet. [1990.08]
[Infantile constipation and Allomin-lactulose. Treatment of infantile obstipation in infants fed with breast milk substitutes. A controlled clinical trial of 2 per cent and 4 per cent Allomin-lactulose] [1990.06.18]
Successful use of vancomycin hydrochloride in the treatment of lactulose resistant chronic hepatic encephalopathy. [1990.06]
[Crystalline lactulose and oral preparations of micro-organisms for the treatment of chronic aspecific diarrhea in children. A controlled clinical study] [1990.04]
Hydrogen excretion after ingestion of five different sugar alcohols and lactulose. [1989.12]
Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study. [1989.03]
Lactitol vs. lactulose in the treatment of chronic recurrent portal-systemic encephalopathy. [1988.08]
Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. [1987.11]
Enterococcus lactic acid bacteria strain SF68 and lactulose in hepatic encephalopathy: a controlled study. [1987.11]
Effect of four days of preoperative lactulose on posthaemorrhoidectomy pain: results of placebo controlled trial. [1987.08.08]
Well-designed clinical trials possibly related to Kristalose (Lactulose)
Profound haemodilution during normothermic cardiopulmonary bypass influences neither gastrointestinal permeability nor cytokine release in coronary artery bypass graft surgery. [2009.10]
A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy. [2009.09]
Retroperitoneal repair of abdominal aortic aneurysm reduces bowel dysfunction. [2009.06]
Impact of anti-Giardia and anthelminthic treatment on infant growth and intestinal permeability in rural Bangladesh: a randomised double-blind controlled study. [2009.05]
Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: a multicentre randomised controlled trial (NTRTC: 1571). [2009.03.18]
Molecular ecological analysis of fecal bacterial populations from term infants fed formula supplemented with selected blends of prebiotics. [2009.02]
Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome. [2008.10.15]
[Effects of enteral nutrition supplemented with glutamine and arginine on gut barrier in patients with severe acute pancreatitis: a prospective randomized controlled trial] [2008.09.09]
Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhea-predominant irritable bowel syndrome. [2008.07.30]
Fluid restriction during running increases GI permeability. [2008.03]
Effect of enteral IGF-1 supplementation on feeding tolerance, growth, and gut permeability in enterally fed premature neonates. [2008.02]
[Forlax in the treatment of childhood constipation: a randomized, controlled, multicenter clinical study.] [2007.10]
Effects of oral adenosine 5'-triphosphate and adenosine in enteric-coated capsules on indomethacin-induced permeability changes in the human small intestine: a randomized cross-over study. [2007.06.19]
Peppermint oil (Mintoil((R))) in the treatment of irritable bowel syndrome: A prospective double blind placebo-controlled randomized trial. [2007.06]
Randomised clinical trial of a laxative alone versus a laxative and a bulking agent after primary repair of obstetric anal sphincter injury. [2007.06]
Enteral resuscitation and early enteral feeding in children with major burns--effect on McFarlane response to stress. [2007.06]
Noninvasive measurement of transit time in short bowel syndrome. [2007.05]
Glutamine and recombinant human growth hormone protect intestinal barrier function following portal hypertension surgery. [2007.04.21]
Peppermint oil (Mintoil((R))) in the treatment of irritable bowel syndrome: A prospective double blind placebo-controlled randomized trial. [2007.04.07]
Wasting and intestinal barrier function in children taking alanyl-glutamine-supplemented enteral formula. [2007.03]
|
